References
- de CairesSSteenkampV Use of Yokukansan (TJ-54) in the treatment of neurological disorders: a reviewPhytother Res20102491265127020812276
- MiyaokaTFuruyaMYasudaHYi-gan san as adjunctive therapy for treatment-resistant schizophrenia: an open-label studyClin Neuropharmacol20093216919471183
- MiyaokaTFuruyaMYasudaHYi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label studyProg Neuropsychopharmacol Biol Psychiatry200832376176418201810
- MiyaokaTFuruyaMYasudaHHayashiaMInagakiTHoriguchiJYi-gan san for the treatment of borderline personality disorder: an open-label studyProg Neuropsychopharmacol Biol Psychiatry200832115015417765378
- SatohTTakahashiTIwasakiKTraditional Chinese medicine on four patients with Huntington’s diseaseMov Disord200924345345519133663
- American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders: DSM-IV; Fourth EditionArlington, VAAmerican Psychiatric Association1994
- OkamotoHReconsideration of Japanese traditional herbal medicine: new field of research and clinical medicineMini Rev Med Chem20066554354716719828
- The Japan Society for Oriental Medicine Introduction to Kampo: Japanese Traditional MedicineTokyoElsevier Japan2005
- TerasawaKKampoTokyoStandard McIntyre1993
- OhtaYKobayashiTNishidaKSasakiEIshiguroIPreventive effect of Oren-gedoku-to (Huanglian-Jie-Du-Tang) extract on the development of stress-induced acute gastric mucosal lesions in ratsJ Ethnopharmacol199967337738410617076
- MonjiATakitaMSamejimaTEffect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer’s diseaseProg Neuropsychopharmacol Biol Psychiatry200933230831119138715
- HayashiYIshidaYInoueTTreatment of behavioral and psychological symptoms of Alzheimer-type dementia with Yokukansan in clinical practiceProg Neuropsychopharmacol Biol Psychiatry201034354154520184936
- OkaharaKIshidaYHayashiYEffects of Yokukansan on behavioral and psychological symptoms of dementia in regular treatment for Alzheimer’s diseaseProg Neuropsychopharmacol Biol Psychiatry201034353253620170698
- YuCJZhengMFKuangCXHuangWDYangQOren-gedoku-to and its constituents with therapeutic potential in Alzheimer’s disease inhibit indoleamine 2, 3-dioxygenase activity in vitroJ Alzheimers Dis201022125726620847417